Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 19/20 | 0.72 |
| ▸ | PPARG | P37231 | 14/20 | 0.70 |
| ▸ | PPARD | Q03181 | 9/20 | 0.70 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5074787 | 1.00 | PPARA (0.72) | PPARAPPARGPPARD | |
| SCHEMBL27674855 | 0.91 | PPARA (0.81) | PPARAPPARGPPARD | |
| SCHEMBL27654986 | 0.90 | PPARA (0.85) | PPARAPPARGPPARD | |
| SCHEMBL6387457 | 0.88 | PPARA (0.56) | PPARAPPARGPPARD | |
| SCHEMBL5015533 | 0.88 | PPARA (0.56) | PPARAPPARGPPARD | |
| SCHEMBL6388507 | 0.87 | PPARA (0.74) | PPARAPPARGPPARD | |
| SCHEMBL4758133 | 0.87 | PPARA (0.74) | PPARAPPARGPPARD | |
| SCHEMBL4755515 | 0.87 | PPARA (0.74) | PPARAPPARGPPARD | |
| SCHEMBL4344001 | 0.86 | PPARA (0.54) | PPARAPPARGPPARD | |
| SCHEMBL6152282 | 0.86 | PPARA (0.72) | PPARAPPARGPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090274674-A1 | Heterocyclic Oxime Compounds, Process for Their Preparation and Pharmaceutical Compositions Containing Them | LES LABORATOIRES SERVIER (FR) | 2009-11-05 | — | — | US | disclosed |
| EP-1966204-A1 | NOVEL HETEROCYCLIC OXIME DERIVATIVES, PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | Les Laboratoires Servier (FR) | 2008-09-10 | — | — | EP | disclosed |
| WO-2007077313-A1 | NOVEL HETEROCYCLIC OXIME DERIVATIVES, PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | LES LABORATOIRES SERVIER (FR) | 2007-07-12 | — | — | WO | disclosed |
| WO-2003053974-A1 | NOVEL COMPOUNDS AND THEIR USE IN MEDICINE, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | DR. REDDY'S LABORATORIES LTD. (IN) | 2003-07-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090274674-A1 | Heterocyclic Oxime Compounds, Process for Their Preparation and Pharmaceutical Compositions Containing Them | CYP3A4, CYP2C19, CYP3A43 | PPARA 1223/4885PPARG 968/4885PPARD 675/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.